Advertisement
Research Article

Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study

  • Khalfan A. Mohammed,

    Affiliations: Programme for Lymphatic Filariasis, Schistosomiasis and Soil-Transmitted Helminthiasis, Ministry of Health and Social Welfare, Zanzibar, United Republic of Tanzania, Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

    X
  • Hamad J. Haji,

    Affiliation: Public Health Laboratory Ivo de Carneri, Chake Chake, Pemba Island, Zanzibar, United Republic of Tanzania

    X
  • Albis-Francesco Gabrielli,

    Affiliation: Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland

    X
  • Likezo Mubila,

    Affiliation: Other Tropical Diseases (OTD), World Health Organization Regional Office for Africa (WHO/AFRO), Belvedere, Harare, Zimbabwe

    X
  • Gautam Biswas,

    Affiliation: Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland

    X
  • Lester Chitsulo,

    Affiliation: Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland

    X
  • Mark H. Bradley,

    Affiliation: Global Community Partnerships, GlaxoSmithKline, Brentford, United Kingdom

    X
  • Dirk Engels,

    Affiliation: Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland

    X
  • Lorenzo Savioli,

    Affiliation: Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland

    X
  • David H. Molyneux mail

    David.Molyneux@liverpool.ac.uk

    Affiliation: Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

    X
  • Published: January 23, 2008
  • DOI: 10.1371/journal.pntd.0000171

About the Authors

Khalfan A. Mohammed
Programme for Lymphatic Filariasis, Schistosomiasis and Soil-Transmitted Helminthiasis, Ministry of Health and Social Welfare, Zanzibar, United Republic of Tanzania
Khalfan A. Mohammed, David H. Molyneux
Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Hamad J. Haji
Public Health Laboratory Ivo de Carneri, Chake Chake, Pemba Island, Zanzibar, United Republic of Tanzania
Albis-Francesco Gabrielli, Gautam Biswas, Lester Chitsulo, Dirk Engels, Lorenzo Savioli
Department of Neglected Tropical Diseases (NTD), World Health Organization, Geneva, Switzerland
Likezo Mubila
Other Tropical Diseases (OTD), World Health Organization Regional Office for Africa (WHO/AFRO), Belvedere, Harare, Zimbabwe
Mark H. Bradley
Global Community Partnerships, GlaxoSmithKline, Brentford, United Kingdom

Corresponding Author

Email: David.Molyneux@liverpool.ac.uk

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Supervised the implementation of the pilot intervention and of the country-wide intervention: DE LS DM. Participated in the development and review of the present manuscript: KM AG. Participated in the implementation of the pilot intervention and of the country-wide intervention: KM HH. Participated in the implementation of the pilot intervention: AG. Contributed to develop the protocol for the pilot intervention: KM HH LM GB LC MB DE LS DM. Reviewed the present manuscript: HH LM GB LC MB DE LS DM.